# Glycation of apoA-I and Diabetic Atherogenesis

> **NCT05659043** · — · UNKNOWN · sponsor: **Ruijin Hospital** · enrollment: 2000 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **OTHER:** overnight fasting

## Key facts

- **NCT ID:** NCT05659043
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2021-12
- **Final completion:** 2023-12
- **Target enrollment:** 2000 (ACTUAL)
- **Last updated:** 2022-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05659043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05659043, "Glycation of apoA-I and Diabetic Atherogenesis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05659043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*